Learn More
Medchemexpress LLC Teneligliptin hydrobromide | 906093-29-6 | 99.8% | 628.86 | 1 ML

Supplier: Medchemexpress LLC HY14806A10MM/1ML
Teneligliptin hydrobromide is an orally active and selective dipeptidyl peptidase 4 (DPP-4) inhibitor, demonstrating IC50s of 0.37 nM for human DPP-4 and 0.29 nM for rat DPP-4. This compound improves blood glucose levels and is utilized in research pertaining to type 2 diabetes mellitus.
- Prevents activation of the NLRP3 inflammasome and associated injury.
- Protects against hypoxia/reoxygenation-induced endothelial cell injury by reducing reactive oxygen species.
- Inhibits inflammation and apoptosis induced by doxorubicin.
- Ameliorates diabetic polyneuropathy and enhances pancreatic β-cell volume and insulin secretion.
- Attenuates myocardial hypertrophy, injury, and inflammatory response in diabetic models.
- Prevents obesity and obesity-related manifestations by boosting energy expenditure.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.